IMCR 8-K 2026-09-14

Immunocore Holdings plc (IMCR) 8-K dated 2026-09-14 — accession 0001671927-26-000026. This URL is the filing, not the IMCR hub.

Immunocore Holdings plc (IMCR) is a biotechnology company listed on NASDAQ.

Immunocore Holdings plc filed a 8-K on 2026-09-14. Accession 0001671927-26-000026.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IMCR revenue for 2025-12-31 was $400.0M. Net income was -$35.5M. Revenue was up 29.0% from 2024-12-31 to 2025-12-31. IMCR currently screens at market cap $1.45B.

Not investment advice. The IMCR SEC hub lists recent forms. The stock page is the research view.